Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413322
Status:
COMPLETED
Last Update Posted:
2015-07-08
First Post:
2006-12-18
Brief Title:
Study of PXD101 Alone and in Combination With 5-Fluorouracil 5-FU in Patients With Advanced Solid Tumors
Sponsor:
Valerio Therapeutics
Organization:
Valerio Therapeutics
Study Overview
Official Title:
A Phase I Safety Pharmacodynamic Anti-Tumor Activity and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study to assess the combination of PXD101 and 5-Fluorouracil 5-FUin patients with advanced solid tumors The primary goal of the study is to understand the safety anti-tumor activity and how the study drug behaves within the body when given with 5-Fluorouracil 5-FU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None